March 7, 2017

GenomOncology and med fusion Expand Services

GenomOncology and med fusion expand lab services to include expression testing to help guide treatment selection of immunotherapeutic checkpoint inhibitors for metastatic non-small cell lung cancer (NSCLC).

Read More  >